/PRZWT/November 14,2024 Gansu-On October 12,2024,the press conference of the Top 500 Private Enterprises in China in 2024,sponsored by the All-China Federation of Industry and Commerce and the People's Government of Gansu Province,was held in Lanzhou.At the conference,lists such as"Top 500 Private Enterprises in China in 2024"and"Top 500 Private Enterprises in Manufacturing in China in 2024"were released.Correction Pharmaceutical Group was selected again,ranking 167th in the Top 500 Private Enterprises in China in 2024 and 115th in the Top 500 Private Enterprises in Manufacturing in China in 2024.
The re-appearance on the list this time highlights the outstanding performance and continuous influence of the correction in the industry.In the past year,we have adhered to the core concept of"Cultivating Morality and Integrity,Creating Infinite",actively expanded the R&D territory,ventured into diabetes,ophthalmology,gastrointestinal digestion and other health fields,and launched more high-quality and affordable medicines,which have effectively benefited the general public.
In the field of public welfare,we adhere to the tenet of"repairing the original yuan and benefiting the common people",not only won the honor of People's Daily Online"2023 Healthy China Innovation Practice Case",but also donated many times to support volunteer doctors'free clinic activities across the country,which further reflects the social responsibility and responsibility of the enterprise.
The coming year 2025 is a glorious moment for the 30th anniversary of the establishment of the correction group.All the revisionists will be full of enthusiasm and unremitting pursuit,relying on the profound cultural heritage of"Conscience Pharmaceutical",and will unswervingly improve the quality of products and services,and strive to present a gift of excellence and achievements to all supporters at this important moment.
